Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05344560 · ClinicalTrials.gov registry record · NA
Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT05344560: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT05344560 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05344560, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
Primary Outcome
Subjective comfort was assessed using Contact Lens User Experience (CLUE) questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (Comfort, Vision, Handling, and Packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution where scores range from 0 to 120 with a population average score of 60 (SD 20). Higher CLUE scores indicate a more favorable/positive res
Interventions
- DEVICE soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore
- DEVICE ACUVUE OASYS 1-Day for Astigmatism
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2022-05-09 |
| Est. Completion | 2022-08-09 |
| Phase | NA |
What the finished NCT05344560 record still lists
NCT05344560 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore is the first listed.
NCT05344560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05344560 about?
NCT05344560 is a clinical study titled "Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light". This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
What is the current status of trial NCT05344560?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2022-05-09. Estimated completion is 2022-08-09.
What interventions are being tested in trial NCT05344560?
The interventions under investigation include: soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore (DEVICE), ACUVUE OASYS 1-Day for Astigmatism (DEVICE).
Who is sponsoring clinical trial NCT05344560?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05344560's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI